An international cannabis business partnership is coming to fruition between an Israeli medical marijuana firm and a New Mexico-based American MMJ company.
The result is the opening of a product manufacturing facility in a suburb north of Albuquerque, The Jerusalem Post reported.
The plant will focus on 18 smokeless MMJ products that are designed to be more scientifically precise for patients who are looking for reliable and repeatable dosages, the Post reported. The base of the product line is made in Israel and then shipped to the United States, and cannabis is added at the New Mexico facility.
The plant was constructed in under six months, and Panaxia is already looking to set up a similar operation in Nevada, the Post reported. Ultra Health has facilities already in both Nevada and Arizona.
The pandemic pivot and how cannabis companies reacted to COVID-19.